Literature DB >> 10752788

A malignant rhabdoid tumor of the kidney occurring concurrently with a brain tumor: report of a case.

Y Adachi1, H Takamatsu, H Noguchi, H Tahara, T Fukushige, T Takasaki, A Yoshida, A Kamenosono, J Kikuchi, M Asatani, K Kawakami.   

Abstract

Malignant rhabdoid tumor of the kidney (MRTK) is one of the most lethal neoplasms to occur in young infants. Cases of MRTK accompanying an embryonal tumor in the central nervous system have occasionally been described. We present herein an interesting case of MRTK that was clinically diagnosed preoperatively. A male infant aged 6 months with both a midline brain tumor and a renal neoplasm was transferred to our institution. Although roentgenographic evaluation suggested that the renal lesion was a Wilms' tumor, midkine (MK), a growth and differentiation factor characteristically present in the urine of patients with Wilms' tumor, was not detected. A preoperative diagnosis of MRTK was established based on the lack of urinary MK in addition to the typical clinical features of the young age and the concurrent brain tumor.

Entities:  

Mesh:

Year:  2000        PMID: 10752788     DOI: 10.1007/s005950050064

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  12 in total

1.  Bone metastasizing renal tumor of childhood: morphological and clinical features, and differences from Wilms' tumor.

Authors:  H B Marsden; W Lawler; P M Kumar
Journal:  Cancer       Date:  1978-10       Impact factor: 6.860

2.  Production of platelet-derived growth factor by cultured Wilms' tumor cells and fetal kidney cells.

Authors:  G E Fraizer; D F Bowen-Pope; A M Vogel
Journal:  J Cell Physiol       Date:  1987-10       Impact factor: 6.384

3.  The association of embryonal tumors originating in the kidney and in the brain. A report of seven cases.

Authors:  J M Bonnin; L J Rubinstein; N F Palmer; J B Beckwith
Journal:  Cancer       Date:  1984-11-15       Impact factor: 6.860

4.  Treatment of Wilms' tumor. Results of the Third National Wilms' Tumor Study.

Authors:  G J D'Angio; N Breslow; J B Beckwith; A Evans; H Baum; A deLorimier; D Fernbach; E Hrabovsky; B Jones; P Kelalis
Journal:  Cancer       Date:  1989-07-15       Impact factor: 6.860

Review 5.  Peripheral and central primitive neuroectodermal tumors. A nosologic concept seeking a consensus.

Authors:  L P Dehner
Journal:  Arch Pathol Lab Med       Date:  1986-11       Impact factor: 5.534

6.  Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1.

Authors:  I A Drummond; S L Madden; P Rohwer-Nutter; G I Bell; V P Sukhatme; F J Rauscher
Journal:  Science       Date:  1992-07-31       Impact factor: 47.728

7.  Malignant rhabdoid tumor. A study with two established cell lines.

Authors:  S Ota; D C Crabbe; T N Tran; T J Triche; H Shimada
Journal:  Cancer       Date:  1993-05-01       Impact factor: 6.860

8.  Insulin-like growth factor-II gene expression in Wilms' tumour and embryonic tissues.

Authors:  J Scott; J Cowell; M E Robertson; L M Priestley; R Wadey; B Hopkins; J Pritchard; G I Bell; L B Rall; C F Graham
Journal:  Nature       Date:  1985 Sep 19-25       Impact factor: 49.962

9.  Clinical aspects of the rhabdoid tumor of the kidney: a report of the National Wilms' Tumor Study Group.

Authors:  N F Palmer; W Sutow
Journal:  Med Pediatr Oncol       Date:  1983

Review 10.  Midkine (MK), the product of a retinoic acid responsive gene, and pleiotrophin constitute a new protein family regulating growth and differentiation.

Authors:  T Muramatsu
Journal:  Int J Dev Biol       Date:  1993-03       Impact factor: 2.203

View more
  1 in total

1.  Coexistence of a colon carcinoma with two distinct renal cell carcinomas: a case report.

Authors:  Alexandros E Papalampros; Athanasios S Petrou; Eleftherios I Mantonakis; Konstantinos I Evangelou; Lambros A Giannopoulos; Georgios G Marinos; Athanasios L Giannopoulos
Journal:  J Med Case Rep       Date:  2011-04-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.